anmelden
OMX Nordic 40
2.707,24
PKT
-25,85
PKT
-0,95
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.10.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 08.10.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 08.10.24 | Nokia Neutral | UBS AG | |
| 08.10.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.10.24 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 04.10.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 03.10.24 | Novo Nordisk Neutral | UBS AG | |
| 03.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.10.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.09.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.09.24 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 27.09.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 27.09.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.09.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.09.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.09.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 26.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 26.09.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 26.09.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 26.09.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 25.09.24 | Volvo (B) Buy | Deutsche Bank AG | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 20.09.24 | Novo Nordisk Neutral | UBS AG | |
| 20.09.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 19.09.24 | Nokia Underweight | Barclays Capital | |
| 18.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.09.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
